Anton Neschadim


  • Joined GreenSky in 2016
  • Founder and CEO of a biotechnology company that develops novel cancer drugs
  • Former Director of Drug Development at a biopharmaceutical company
  • Expertise in chemistry, cancer research, immunology, regenerative medicine and gene therapy
  • Authored more than 25 peer-reviewed publications and patents
  • Co-Founded and former Board of Director of a national science policy conference and centre


  • Hon. BSc, Chemistry and Immunology, University of Toronto
  • MSc, Immunology, University of Toronto
  • MBA, University of Toronto (Rotman)
  • PhD, Medical Biophysics, University of Toronto

In his free time

  • Mentors early-career professionals and entrepreneurs